glycyrrhizic acid has been researched along with cyclosporine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horikawa, M; Kato, Y; Sugiyama, Y; Tyson, CA | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Ohno, A; Sugino, N; Tanaka, M | 1 |
| Chiba, S; Nagata, N; Numazaki, K; Sato, T | 1 |
| Kagami, M; Kayashima, S; Kobari, S; Kondou, T; Watanabe, Y | 1 |
| Chen, L; Chen, YX; Davey, AK; Liu, XQ; Wang, JP; Yang, J | 1 |
| Chao, PD; Hou, YC; Lin, SP | 1 |
| Cui, JY; Li, YX; Ran, XH; Ren, CA; Sheng, ZX; Wang, BH; Zhang, MH | 1 |
1 trial(s) available for glycyrrhizic acid and cyclosporine
| Article | Year |
|---|---|
Efficacy of glycyrrhizin combined with cyclosporine in the treatment of non-severe aplastic anemia.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Cyclosporine; Drug Therapy, Combination; Female; Glycyrrhizic Acid; Humans; Interferon-gamma; Interleukin-2; Male; Middle Aged | 2013 |
8 other study(ies) available for glycyrrhizic acid and cyclosporine
| Article | Year |
|---|---|
The potential for an interaction between MRP2 (ABCC2) and various therapeutic agents: probenecid as a candidate inhibitor of the biliary excretion of irinotecan metabolites.
Topics: | 2002 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
[Drugs and other substances inducing hypertension].
Topics: Antidepressive Agents, Tricyclic; Contraceptives, Oral; Cyclosporine; Danazol; Erythropoietin; Extracellular Space; Glycyrrhetinic Acid; Glycyrrhizic Acid; Humans; Hypertension; Monoamine Oxidase Inhibitors; Recombinant Proteins; Sodium, Dietary | 1992 |
Effect of glycyrrhizin, cyclosporin A, and tumor necrosis factor alpha on infection of U-937 and MRC-5 cells by human cytomegalovirus.
Topics: Antigens, Surface; Base Sequence; Cell Line; Cyclosporine; Cytomegalovirus; DNA, Viral; Fluorescent Antibody Technique; Glycyrrhetinic Acid; Glycyrrhizic Acid; Humans; Lung; Molecular Sequence Data; Monocytes; Polymerase Chain Reaction; Tumor Necrosis Factor-alpha | 1994 |
A patient with non-A, non-B, non-C hepatitis-associated aplastic anemia recovered promptly following immuno-suppressive therapy, including antithymocyte globulin.
Topics: Adult; Anemia, Aplastic; Antilymphocyte Serum; Autoimmune Diseases; Bone Marrow Cells; Combined Modality Therapy; Cyclosporine; Erythrocyte Transfusion; Glycyrrhizic Acid; Granulocyte Colony-Stimulating Factor; Hepatitis, Viral, Human; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lymphocyte Subsets; Male; Methylprednisolone; Oxymetholone; Platelet Transfusion | 1998 |
Effects of diammonium glycyrrhizinate on the pharmacokinetics of aconitine in rats and the potential mechanism.
Topics: Aconitine; Administration, Oral; Animals; Biological Transport; Cyclosporine; Disease Models, Animal; Enzyme Inhibitors; Glycyrrhizic Acid; Intestinal Absorption; Male; Membrane Transport Proteins; Nitrophenols; Rats; Rats, Sprague-Dawley; Time Factors; Verapamil | 2009 |
Liquorice reduced cyclosporine bioavailability by activating P-glycoprotein and CYP 3A.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Cell Line, Tumor; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Glycyrrhiza; Glycyrrhizic Acid; Herb-Drug Interactions; Humans; Male; Plant Extracts; Plant Roots; Rats; Rats, Sprague-Dawley | 2012 |